This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastrointestinal stromal tumors (GIST) are a type of cancer that occurs in the digestive system (gastrointestinal tract). GIST is a rare form of cancer, accounting for less than 1% of all gastrointestinal cancers. GIST can develop anywhere in the digestive system, but are most commonly found in the stomach and small intestine. GIST is usually diagnosed in people over the age of 50, although it can occur in younger people as well. The exact cause of GIST is unknown, but it is thought to be related to a genetic mutation that affects certain cells in the digestive system. GIST is often asymptomatic, but can cause a variety of symptoms, depending on its size and location. These symptoms can include abdominal pain, nausea, vomiting, weight loss, and changes in bowel habits. If the tumor is large, it can cause a feeling of fullness in the abdomen, as well as pain or discomfort. In some cases, GIST can cause bleeding or obstruction in the digestive system, leading to anaemia and other problems. Diagnosis of GIST is usually done through imaging tests such as CT scans or MRI, and biopsy of the tumor. Treatment of GIST usually involves surgery to remove the tumor, although in some cases medication or radiation therapy may be used. Surgery is the most common treatment for GIST, and the goal of surgery is to remove the entire tumor. In some cases, chemotherapy may be recommended to treat residual tumor cells or to reduce the risk of local recurrence. GIST can be a serious condition, but with early diagnosis and appropriate treatment, most people can have a good outcome. It is important to seek medical attention if you have any of the symptoms associated with GIST.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States